Target- |
MechanismDNA methylation inhibitors |
|
|
|
|
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Chengdu Daoboqin Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Chengdu Daoboqin Pharmaceutical Technology Co., Ltd.
100 Deals associated with Chengdu Daoboqin Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Chengdu Daoboqin Pharmaceutical Technology Co., Ltd.